Intuitive Surgical’s Da Vinci 5 System Receives CE Mark, Expands Advanced Robotic Surgery Access Across Europe

Intuitive Surgical Inc. (NASDAQ:ISRG) is one of the best US stocks to buy and hold in 2025. On July 2, Intuitive Surgical announced that its latest da Vinci 5 Surgical System received CE mark approval. This regulatory milestone enables the system’s use across adult and pediatric patients in Europe for a spectrum of minimally invasive endoscopic procedures, such as abdominopelvic and thoracoscopic surgeries in urology, gynecology, and general laparoscopy.

The da Vinci 5 introduces 50+ enhancements on the foundational da Vinci Xi Surgical System. Key innovations include first-of-its-kind Force Feedback-enabled technology, which allows surgeons to sense pressure and tension during operations. It also features Intuitive’s most realistic 3D vision system to date. The system supports 10,000x more computing power than previous models. There’s also greater surgeon autonomy through integrated components controlled at the fingertips, a universal user interface for care teams, and dynamic assistance to automate select tasks.

A medical team performing minimally invasive surgery with a da Vinci Surgical System.

In 2024, the US FDA had already granted 510(k) clearance for the da Vinci 5 Surgical System for use in urology, general, gynecology, and thoracic procedures in adults. In 2024, surgeons performed 410,000+ procedures in Europe using da Vinci systems, contributing to ~17 million procedures performed worldwide to date with Intuitive’s technology.

Intuitive Surgical Inc. (NASDAQ:ISRG) develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.